Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Insulin Resistance 3Diabetes Mellitus, Type 2 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Diabetes Mellitus 2Carotid Intimal Medial Thickness 1 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Skin Neoplasms 1Prostatic Neoplasms 1Pharmacokinetics of MDV3100 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Liposarcoma, Myxoid 1Liposarcoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Chronic-Phase 1Inflammation 1Head and Neck Neoplasms 1Glioblastoma 1Cognitive Dysfunction 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Pioglitazone × Clear all
NCT02958956 2018-03-07

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Takeda

Completed
236,507 enrolled 13 charts

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡